ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 387

$603K Total Retail Price of All Prescriptions

Rank: 102 out of 387

258 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 258 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 258 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 369 319 1 2
OMEPRAZOLE 328 246 2 4
LISINOPRIL 237 179 3 3
CARVEDILOL 201 144 4 21
ATORVASTATIN CALCIUM 189 161 5 13
SIMVASTATIN 179 120 6 5
AMLODIPINE BESYLATE 178 158 7 6
SERTRALINE HCL 171 117 8 23
ZOLPIDEM TARTRATE 165 132 9 16
CITALOPRAM HBR 158 86 10 19
HYDROCODONE-ACETAMINOPHEN 156 95 S3 11 1
NEXIUM 146 76 12 26
METFORMIN HCL 144 73 13 8
FUROSEMIDE 126 79 14 7
CYCLOBENZAPRINE HCL 111 61 R 15 42
POTASSIUM CHLORIDE 104 78 16 9
METOPROLOL SUCCINATE 103 76 17 18
HYDROCHLOROTHIAZIDE 102 73 18 12
FLUTICASONE PROPIONATE 100 51 19 29
GABAPENTIN 93 64 20 10
LYRICA 81 66 21 66
PRAVASTATIN SODIUM 79 65 22 15
BUSPIRONE HCL 74 45 23 121
TRAMADOL HCL 71 44 24 14
PAROXETINE HCL 69 52 25 52
LEVOXYL 69 41 25 216
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 67 27 30
DONEPEZIL HCL 64 64 28 27
SEROQUEL XR 64 37 28 235
DIGOXIN 62 44 30 40
VENLAFAXINE HCL ER 62 24 30 97
MELOXICAM 62 42 30 22
NAMENDA 59 48 33 35
CRESTOR 56 31 34 34
TRAZODONE HCL 55 32 35 37
NAPROXEN 53 35 36 89
PROAIR HFA 53 20 36 47
JANUVIA 51 28 38 60
RISPERIDONE 51 0 38 70
LIPITOR 50 29 40 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.